AN important policy contradiction has been exposed by the current debate over the proposed amendments to Statutory Instrument 330 of 2000, with analysts and health experts saying the SI need more serious reflection from key stakeholders.
That contradiction now sits at the centre of the growing dispute between healthcare funders and policymakers over reforms that could fundamentally reshape Zimbabwe’s private healthcare sector.
Through the Association of Health Funders of Zimbabwe (AHFoZ), medical aid societies have approached Parliament seeking reconsideration of aspects of the proposed amendments, warning that some of the reforms could produce unintended consequences for healthcare affordability, investment and long-term system sustainability.
At issue is a proposal that would restrict or separate medical aid societies from owning or investing in healthcare infrastructure such as hospitals, pharmacies, laboratories and clinics — a model broadly associated with integrated healthcare delivery systems.
The argument appears straightforward: medical aid societies should finance healthcare rather than participate directly in healthcare provision.
But healthcare systems rarely operate according to neat theoretical distinctions.
Healthcare is not merely a financing mechanism.
It is an interconnected ecosystem in which infrastructure, pricing, capital investment, risk management and service delivery continuously shape one another. Once one component weakens, pressure spreads quickly across the broader system.
That reality explains why integrated healthcare structures have emerged across many advanced healthcare economies.
In the United States, Kaiser Permanente’s model — combining insurance, hospitals and physician networks — has long been studied for its ability to align financing with healthcare delivery while containing long-term costs. Singapore’s healthcare system similarly relies on highly coordinated relationships between financing mechanisms, hospitals and state-supported infrastructure to maintain some of the world’s strongest healthcare outcomes at comparatively controlled costs.
Across Europe, countries such as the Netherlands and Germany have increasingly moved toward integrated care systems designed to improve coordination, efficiency and sustainability rather than fragment healthcare delivery further. Even the United Kingdom’s National Health Service has spent years restructuring toward integrated care systems aimed at improving coordination between funding, hospitals and patient care.
The international direction of travel is therefore increasingly toward coordination and integration rather than fragmentation.
Zimbabwe should be cautious about moving in the opposite direction without fully understanding the consequences.
And perhaps the clearest local example explaining why integration matters can be found outside healthcare altogether.
Zimbabwe’s funeral assurance sector has evolved beyond simply selling funeral policies into broader ecosystems incorporating funeral parlours, transport systems, memorial parks and burial infrastructure. These integrated models are widely regarded as commercially rational because they improve operational sustainability, service reliability and long-term affordability.
Few people question the logic behind that approach.
The reason is simple.
A low-cost funeral assurance product cannot remain sustainable if every service across the value chain depends entirely on external providers charging uncontrolled market prices. The model works partly because providers retain influence over infrastructure, logistics and the cost structures connected to service delivery.
Without that coordination, costs would become more volatile, premiums would rise and affordability would weaken over time.
Healthcare financing operates under similar economic pressures, only at a far greater level of complexity.
Medical aid societies do not invest in healthcare infrastructure merely for expansion. Coordinated provider systems help healthcare funders negotiate tariffs, stabilise costs, manage service delivery and preserve affordability for members in an environment already characterised by high medical inflation and constrained household incomes.
The proposed reforms would leave healthcare funders carrying substantial financial risk while limiting their influence over the cost structures driving healthcare delivery itself.
That imbalance is precisely what healthcare stakeholders are warning against.
Submissions presented to Parliament by First Mutual Health cautioned that the proposed amendments could result in “reduced healthcare access and service availability” as well as “reduced healthcare investment and supply capacity.”
The organisation also warned of “increased pressure on public health facilities” and possible “forced disposal of healthcare assets and loss of investment value.”
Another submission by Bonvie Medical Aid Scheme and Vivat Health Solutions warned that under the proposed framework, “medical aids lose negotiating power — providers set unchecked pricing.”
That concern should not be dismissed lightly.
Healthcare markets do not naturally regulate themselves in favour of affordability. When financing systems lose leverage over pricing and delivery structures, costs often escalate faster than household incomes can absorb.
The likely consequences are familiar: rising medical aid subscriptions, shrinking coverage, reduced employer support, delayed treatment, healthcare worker migration and mounting pressure on already strained public hospitals.
Eventually, the burden shifts back onto citizens and the state.
In fragile economies, healthcare stability is not merely a social issue but a foundation for labour productivity, investment confidence and broader economic resilience.
None of this means the current healthcare financing system is beyond criticism. Legitimate concerns around governance, transparency and accountability deserve attention. Parliament is right to scrutinise the sector carefully.
But there is an important difference between reforming a system and weakening the structures that help keep it functional.
Good policy should ultimately be judged by outcomes rather than appearances or political appeal.
The central question is not whether integrated healthcare systems are theoretically untidy.
The real question is whether ordinary Zimbabweans will still be able to access affordable healthcare if those systems are dismantled without viable alternatives in place.
That is the test Parliament must apply carefully.
Because healthcare systems rarely fail dramatically. More often, they deteriorate gradually through rising costs, shrinking access, declining investment and exhausted public institutions carrying pressures they were never adequately designed to absorb.
The danger is not that Zimbabwe reforms its healthcare system. The danger is that it weakens one of the few mechanisms still preventing deeper healthcare instability before a credible alternative is ready to replace it.
